HLIFinancial Services · Capital MarketsThe 11 Wall Street analysts covering Houlihan Lokey, Inc. hold a median 12-month price target of $150 — +19.5% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 37 of 100 as at 1 Aug 2026 — in the lower half. The Street sees upside; the factor read is a caution. That gap is the story on this page.
Consensus tells you what everyone already believes. The model scores Houlihan Lokey, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.
Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested
Quality (97): The business earns solid, repeatable profits on what it owns.
Accruals (27): A large share of reported profit has not shown up as cash, or the balance sheet is expanding quickly — both tend to unwind.
Size (17): Larger than most of the companies we track — more scrutinised, less often mispriced.
The rank is the raw material. Whether the rules would actually own Houlihan Lokey, Inc. — and when they’d sell — is the membership.
The bullish and bearish analyst opinions on HLI, reported as data — targets and ratings, the market's view beside the model's.
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
The green dot is the last close — the median target sits +19.5% from it.
Of the 20 most recent actions, 1 moved their price target up and 7 moved it down.
| Date | Firm | Action | Rating | Target |
|---|---|---|---|---|
| 3 Aug 2026 | BMO Capital | Maintains | Outperform | $160 → $145 |
| 30 July 2026 | Goldman Sachs | Maintains | Buy | $171 → $148 |
| 30 July 2026 | Keefe, Bruyette & Woods | Maintains | Outperform | $160 → $153 |
| 30 July 2026 | Morgan Stanley | Maintains | Overweight | $187 → $177 |
| 30 July 2026 | UBS | Maintains | Neutral | $161 → $147 |
| 10 July 2026 | Keefe, Bruyette & Woods | Maintains | Outperform | $172 → $160 |
| 10 July 2026 | Keefe, Bruyette & Woods | Maintains | Outperform | — |
| 9 July 2026 | Morgan Stanley | Maintains | Overweight | $193 → $187 |
| 9 July 2026 | Morgan Stanley | Maintains | Overweight | — |
| 8 July 2026 | UBS | Maintains | Neutral | — |
| 8 July 2026 | UBS | Maintains | Neutral | $160 → $161 |
| 7 May 2026 | Keefe, Bruyette & Woods | Maintains | Outperform | — |
| 9 Apr 2026 | Morgan Stanley | Maintains | Overweight | — |
| 1 Apr 2026 | Goldman Sachs | Maintains | Buy | — |
| 12 Mar 2026 | Goldman Sachs | Maintains | Buy | — |
| 12 Mar 2026 | UBS | Maintains | Neutral | — |
| 29 Jan 2026 | BMO Capital | Maintains | Outperform | — |
| 29 Jan 2026 | Keefe, Bruyette & Woods | Maintains | Outperform | — |
| 8 Jan 2026 | Keefe, Bruyette & Woods | Maintains | Outperform | — |
| 6 Jan 2026 | Morgan Stanley | Maintains | Overweight | — |
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.
A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.
Cheaper than 37% of US stocks
Cheaper than 37% of US stocks
Cheaper than 28% of US stocks
Cheaper than 34% of US stocks
Higher than 12% of US stocks
Higher than 20% of US stocks
Higher than 49% of US stocks
Higher than 78% of US stocks
Higher than 79% of US stocks
Higher than 79% of US stocks
Higher than 94% of US stocks
Higher than 50% of US dividend payers
Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.
The nearest names by industry and size, scored by the same model — like for like.
Computed off the Friday close and sent before the US open.
Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. HLI appears on the weeks it earns a place.
Houlihan Lokey reported first-quarter fiscal 2027 revenue of $511 million and adjusted earnings per share of $1.35. Management characterized the quarter as a temporary disruption rather than a fundamental change in its outlook.
Why it matters — An HLI watcher would note management's view that the quarter represents a temporary disruption, suggesting no permanent shift in the company's underlying business trajectory.
Houlihan Lokey reported Q1 earnings of $1.35 per share, missing the Zacks Consensus Estimate of $1.64 per share and falling from $2.14 per share a year ago.
Why it matters — A miss on both earnings and revenue estimates, along with a year-over-year decline, signals weaker-than-expected performance for the quarter.
Houlihan Lokey, Inc. held its Q1 2027 earnings call, and the transcript of that call has been published by Seeking Alpha.
Why it matters — Earnings call transcripts provide detailed insights into the company's financial performance and management commentary for the quarter.
Houlihan Lokey reported its quarterly results for the period ending June 2026, with the article suggesting investors compare key metrics to both analyst estimates and prior-year figures.
Why it matters — The comparison of HLI's key metrics to Wall Street estimates and year-ago actuals provides context for assessing the company's recent operational performance.
Houlihan Lokey reported financial results for the first quarter of fiscal 2027, with revenues of $511 million and net income of $78 million ($1.15 per diluted share), compared to revenues of $605 million and net income of $98 million ($1.42 per diluted share) in the same quarter last year.
Why it matters — The year-over-year declines in both revenue and net income signal a weaker start to the fiscal year for Houlihan Lokey compared to the prior-year period.
The 11 Wall Street analysts covering Houlihan Lokey, Inc. have a median 12-month price target of $150, with estimates ranging from $145 to $177. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.
Of the 11 analysts covering Houlihan Lokey, Inc., 5 rate it a Buy, 6 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks Houlihan Lokey, Inc. 37 out of 100 across roughly 4,600 US stocks as at 1 Aug 2026. None of this is personal advice — it does not consider your circumstances.
As at 1 Aug 2026, Houlihan Lokey, Inc. ranks 37 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Quality (97 of 100).
No one can know that. What the data says: the median 12-month target from 11 analysts implies +19.5% from the last close, and Ticker Nerd's factor model ranks Houlihan Lokey, Inc. 37 out of 100 as at 1 Aug 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.
No analyst covering Houlihan Lokey, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for HLI are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $145 to $177 over the next 12 months.
Houlihan Lokey, Inc. returned -32.9% over the 12 months to 3 Aug 2026, with dividends reinvested. Past performance does not indicate future returns.
Houlihan Lokey Inc. is a leading global investment bank known for providing advisory services in financial restructuring, corporate finance, and financial valuation.
The most recent item we track (MarketBeat, 30 July 2026): "Houlihan Lokey Q1 Earnings Call Highlights". Houlihan Lokey reported first-quarter fiscal 2027 revenue of $511 million and adjusted earnings per share of $1.35. Management characterized the quarter as a temporary disruption rather than a fundamental change in its outlook.
Houlihan Lokey Inc. is a leading global investment bank known for providing advisory services in financial restructuring, corporate finance, and financial valuation. The primary role of Houlihan Lokey is to offer expert guidance to corporations and governments in navigating complex financial situations. It is particularly renowned for its restructuring practice, having advised numerous high-profile clients on debt restructurings, distressed mergers and acquisitions, and bankruptcy situations. Houlihan Lokey serves a diverse client base that spans across various industries, including technology, healthcare, energy, and financial services, providing sector-specific knowledge and expertise to tailor solutions effectively. As a result, the firm plays a crucial role in helping clients optimize capital structures and enhance enterprise value. With its extensive global reach, Houlihan Lokey maintains a significant presence in major financial markets, positioning itself as a key player in the investment banking sector. Founded in 1972 and headquartered in Los Angeles, California, the firm has built a reputation for excellence in delivering strategic financial solutions and fostering long-term client relationships.
CEO Mr. Scott Joseph Adelson · 2,800 employees · United States · https://hl.com